Patents by Inventor David R. Andrew

David R. Andrew has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 4885293
    Abstract: Pharmaceutical compositions and a method for reducing intraocular pressure by topically applying a carboxyalkyl dipeptide are disclosed.
    Type: Grant
    Filed: July 30, 1986
    Date of Patent: December 5, 1989
    Assignee: Schering Corporation
    Inventors: David R. Andrews, Federico C. A. Gaeta, Robert W. Watkins
  • Patent number: 4826816
    Abstract: Antihypertensive compounds with angiotensin-converting enzyme inhibitory activity and diuretic activity are disclosed. Such compounds are useful in the treatment of cardiovascular disorders, especially hypertension and congestive heart failure, and are useful in the treatment of glaucoma.
    Type: Grant
    Filed: October 4, 1985
    Date of Patent: May 2, 1989
    Assignee: Schering Corporation
    Inventors: David R. Andrews, Federico C. A. Gaeta
  • Patent number: 4778795
    Abstract: Methods and pharmaceutical compositions are disclosed for reducing intraocular pressure. The methods and compositions employ an active ingredient which comprises certain benzothiadiazinyl and quinazolinyl substituted carboxyalkyl dipeptides wherein the benzothiadiazinyl or quinazolinyl portions are joined to the dipeptide portions by an aminocarbonyl group.
    Type: Grant
    Filed: September 3, 1986
    Date of Patent: October 18, 1988
    Assignee: Schering Corporation
    Inventors: Bernard R. Neustadt, David R. Andrews, Paul E. McNamara, Robert W. Watkins
  • Patent number: 4634698
    Abstract: Pharmaceutical compositions and a method for reducing intraocular pressure by topically applying a carboxyalkyl dipeptide are disclosed.
    Type: Grant
    Filed: April 8, 1985
    Date of Patent: January 6, 1987
    Assignee: Schering Corporation
    Inventors: David R. Andrews, Federico C. A. Gaeta
  • Patent number: 4616012
    Abstract: Methods and pharmaceutical compositions are disclosed for reducing intraocular pressure. The methods and compositions employ an active ingredient which comprises certain benzothiadiazinyl and quinazolinyl substituted carboxyalkyl dipeptides wherein the benzothiadiazinyl or quinazolinyl portions are joined to the dipeptide portions by an aminocarbonyl group.
    Type: Grant
    Filed: November 12, 1985
    Date of Patent: October 7, 1986
    Assignee: Schering Corporation
    Inventors: Bernard R. Neustadt, David R. Andrews, Paul E. McNamara, Robert W. Watkins
  • Patent number: 4559340
    Abstract: There are disclosed benzothiadiazinyl and quinazolinyl substituted carboxylalkyl dipeptides, wherein the benzothiodiazinyl or quinazolinyl portions are joined to the dipeptide portions by an aminocarbonyl group. Compounds of this invention are useful as antihypertensive agents, in the treatment of congestive heart failure and in the treatment of glaucoma. In addition, compounds of this invention have diuretic activity.
    Type: Grant
    Filed: November 25, 1983
    Date of Patent: December 17, 1985
    Assignee: Schering Corporation
    Inventors: Bernard R. Neustadt, David R. Andrews, Paul E. McNamara
  • Patent number: 4556655
    Abstract: Antihypertensive compounds with angiotensin-converting enzyme inhibitory activity and diuretic activity are disclosed. Such compounds are useful in the treatment of cardiovascular disorders, especially hypertension and congestive heart failure, and are useful in the treatment of glaucoma.
    Type: Grant
    Filed: September 24, 1984
    Date of Patent: December 3, 1985
    Assignee: Schering Corporation
    Inventors: David R. Andrews, Federico C. A. Gaeta